2nd International Congress Clinically Relevant Drug Transporters
Main areas of discussions will be:
• Effective testing and modelling methodology
• In vitro-to-in vivo and preclinical-to-clinical translation of transport data
• Impact of regulatory authorities and the ITC whitepaper
• The impact of membrane transporters on drug development programmes
On 12 and 13 April, delegates will hear case studies from leading companies and institutions in the field of drug transporters such as Sanofi-Aventis Deutschland GmbH, Johnson & Johnson, Belgium, the University of Toronto, Canada and the University of Tokyo, Japan.
During the Interactive Workshop Day on 14 April, delegates can enhance their knowledge of topics such as:
• Neurovascular unit and biochemical barrier function
• Modelling of transporter driven DDI
• Model-based drug development: Incorporating population variability into mechanistic prediction of PK and modelling of PK-PD
• Species differences in drug transport and drug metabolism - do we have good enough experimental models to work with?
Further information, including the full conference program and additional content downloads, are available on www.drug-transporters.com/PR
IQPC provides business solutions around the world with tailored practical conferences, large scale events, topical seminars and in-house training programs, keeping them up-to-date with industry trends, technological developments and the regulatory landscape. IQPC produces more than 1,500 events annually around the world, and continues to grow. IQPC has offices in major cities across six continents including: Bengaluru, Berlin, Dubai, London, New York, Sao Paulo, Singapore and Sydney. IQPC leverages a global research base of best practices to produce an unrivalled portfolio of conferences.